---
title: "RINGPU obtained a new veterinary drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259472449.md"
description: "RINGPU recently obtained a new veterinary drug registration certificate issued by the Ministry of Agriculture and Rural Affairs, involving a four-in-one inactivated vaccine for Newcastle disease, infectious bronchitis, avian influenza (H9 subtype), and infectious bursal disease. This product fills a gap in the domestic market, demonstrating the company's innovative capabilities in the poultry vaccine field, further consolidating its market position, and will bring new performance growth points for the company"
datetime: "2025-09-30T08:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259472449.md)
  - [en](https://longbridge.com/en/news/259472449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259472449.md)
generator: "portal-rs"
---

# RINGPU obtained a new veterinary drug registration certificate

According to the announcement from Zhitong Finance APP, RINGPU (300119.SZ) has released a notice stating that, in accordance with the "Regulations on Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs," the company and its subsidiaries, Tianjin RINGPU Biotechnology Co., Ltd. Airport Economic Zone Branch, RINGPU (Baoding) Biopharmaceutical Co., Ltd., and Guangzhou South China Agricultural University Biopharmaceutical Co., Ltd., have recently obtained the "New Veterinary Drug Registration Certificate" issued by the Ministry of Agriculture and Rural Affairs. The name of the new veterinary drug is: Inactivated vaccine for Newcastle disease, infectious bronchitis, avian influenza (H9 subtype), and infectious bursal disease (LaSota strain + RPVA0406 strain + TJ-4 strain + RPVA0706 strain).

The approval of this product fills the market gap for QX-type infectious bronchitis virus multivalent vaccines for chickens in China, reflecting the company's forward-looking layout and innovative strength in the field of poultry vaccines, improving the company's poultry vaccine product line, helping to further consolidate the company's leading position in the poultry vaccine sector, and will bring new performance growth points for the company

### Related Stocks

- [300119.CN](https://longbridge.com/en/quote/300119.CN.md)

## Related News & Research

- [TMP Group designs, builds Parma Calcio-AdmiralBet.news hospitality areas at Tardini stadium](https://longbridge.com/en/news/296793284.md)
- [One seemingly ordinary job has gotten much more deadly over the past 10 years, federal data shows](https://longbridge.com/en/news/296704689.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [Guolian Minsheng Securities files board, committee member list and disclosure-responsible management roster](https://longbridge.com/en/news/296613261.md)
- [CSG-owned Federal Ammunition wins Nordic Police contract for up to 35 million rifle rounds](https://longbridge.com/en/news/296496114.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**